The latest price target for SELLAS Life Sciences Gr (NASDAQ:SLS) was reported by Cantor Fitzgerald on November 22, 2023. The analyst firm set a price target for $3.00 expecting SLS to rise to within 12 months (a possible 219.83% upside). 0 analyst firms have reported ratings in the last year.

The latest analyst rating for SELLAS Life Sciences Gr (NASDAQ:SLS) was provided by Cantor Fitzgerald, and SELLAS Life Sciences Gr reiterated their overweight rating.

There is no last upgrade for SELLAS Life Sciences Gr

There is no last downgrade for SELLAS Life Sciences Gr.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SELLAS Life Sciences Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SELLAS Life Sciences Gr was filed on November 22, 2023 so you should expect the next rating to be made available sometime around November 22, 2024.

While ratings are subjective and will change, the latest SELLAS Life Sciences Gr (SLS) rating was a reiterated with a price target of $0.00 to $3.00. The current price SELLAS Life Sciences Gr (SLS) is trading at is $0.94, which is within the analyst’s predicted range.